OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Heart and Lung Transplantation is 0. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)

Article	Citations
Factors Associated with Prolonged Length of Stay After Pediatric Heart Transplantation	473
Methods and Preliminary Results of Implementation of Multi-Center Earlyimpella® Support in Patients with St-Segment Elevation Myocardial Infarction Complicated by Cardiogenic Shock (RECOVER IV) Trial	215
Correlation Between Donor-Specific Antibodies and Molecular Microscope Results in Heart Transplant Recipients	107
Machine Learning Models as an Accurate Predictor of Survival in Pediatric Heart Transplant	97
Evaluation of Pulmonary Vasodilator Efficacy in LVAD Patients Using Invasive Right Heart Catheter Stress Testing	95
Lung Transplant Using Extra-Corporeal Membrane Oxygenation: Outcomes and Predictors of Conversion to Cardiopulmonary Bypass	91
Waitlist Mortality for Patients with Cardiac Allograft Vasculopathy Under the 2018 UNOS Donor Heart Allocation System	89
Micro-RNA Biomarkers of Allograft Rejection in Pediatric Heart Transplantation	83
Genome-Wide DNA Methylation Profiling in Human Dilated Cardiomyopathy	72
Long Term Use of Implantable Left Ventricular Assist Devices in Pediatric Patients	66
Early Onset Malignancy in the First-Year After Heart Transplantation	62
Comparison Between Waiting List Diagnosis for Lung Transplantation for Pulmonary Interstitial Disease and Explant Analysis from the Largest Lung Transplantation Group of Brazil	62
Older Donor Hearts for Heart Transplantation	60
WITHDRAWN	59
Impact of Preoperative Left Ventricular Ejection Fraction on Outcomes After Pulmonary Thromboendarterectomy for Chronic Thromboembolic Pulmonary Hypertension	57
Comparative Analysis of Fontan Transplant Outcomes	56
Recurrent Migration of a Protekduo Right Ventricular Assist Device: A Case Report	55
Utilization of Distressed Communities Index to Examine the Impact of Socioeconomic Status on Left Ventricular Assist Device Outcomes	55
Assessing a Conservative Anticoagulation Protocol Following Gastrointestinal Bleeding in Patients with a HeartMate 3 LVAD	55
Out-Of-Hospital Cardiac Arrest Donor (OHCAd) Hearts: A Single-Center Experience	53
When to Wait, When to Act: A Single-Center Retrospective Review of Patients with Advanced Lung Disease Deemed 'Too Early' to List for Lung Transplantation	51
Donor Derived Cell Free DNA is a Reliable Marker in High Risk Heart Transplant Patients	50
Pulseless Paradoxus in a Heartmate3 Recipient with Cardiac Tamponade	48
Title: Clinical Outcomes of Lung Transplant Recipients with Myelodysplastic Syndrome and Short Telomere Syndrome	47
Impact and Outcomes of Hepatitis C Viremic Donors (HCV-NAAT) on Donor-Derived Cell-Free DNA Levels and Gene-Expresion Profiling (GEP-Allomap) in Heart Transplant Recipients	47

Association of Neighborhood-Level Social Disinvestment with Worse Survival After Lung Transplant is Mediated by Individual Insurance Status	46
Utility of Breath Volatomic Analysis in Lung Transplant Recipients	45
Single Cell Analysis of Bronchiolar Brushings Identifies Basal Cell Loss in CLAD	43
Disseminated Mycobacterium Tuberculosis Post Lung Transplantation	42
Outcomes of Lung Transplantation for Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Stem Cell Transplantation Compared with Interstitial Pulmonary Fibrosis	42
A High Pulmonary-to-Systemic Arterial Elastance Ratio is a Powerful Predictor of Poor Outcomes After Heart Transplantation: A Clinical Study with Physiological Insights from Digital Twin Models	42
Heart Transplant in Transthyretin Cardiac Amyloidosis: A Single-Center Experience	41
Plasma Proteins Ameliorate Loss of Coronary Vascular Resistance During Working Mode Normothermic Ex-Situ Heart Perfusion	41
MINIMALLY INVASIVE PULMONARY ENDARTERECTOMY THROUGH INVERTED-T UPPER HEMISTERNOTOMY	40
INOPERABLE CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION:EVOLUTION OF PROGNOSIS IN 10 YEARS OF NEW EMERGING THERAPIES	40
Primary graft dysfunction, dysbiosis, and innate immune activation after lung transplantation	37
Going the distance: Long-term follow-up of the randomized, prospective Scandinavian heart transplant everolimus de novo study with early calcineurin inhibitors avoidance (SCHEDULE) trial	37
Ex-vivo lung perfusion: National trends and post-transplant outcomes	36
Safety of Erythropoiesis-Stimulating Agents for Pediatric Berlin EXCOR VAD Patients	36
Exercise Test and Hemodynamic Outcomes in Heart Transplant Patients Treated with Long-Term Mechanical Circulatory Support as Bridge to Transplantation	36
Amyloid Unmasked: A Rare Case of Apolipoprotein A- IV Cardiac Amyloidosis	35
Extent of Pulmonary Vascular Resistance Reduction with Temporary Mechanical Circulatory Devices Among Patients Awaiting Cardiac Transplantation	34
Living-Donor Single-Lobe Lung Transplantation: A Single-Center Case Series	34
Evaluation of Platelet Activation by Flow Cytometry in Contemporary Continuous Flow Left Ventricular Assist Device Support	34
Organ Care System (OCS) Perfusion Time During Donation After Circulatory Death (DCD) Heart Transplantation: Not Too Little, Not Too Much: There Safety Lie	33
Cardiac Tamponade Associated to an Early EBV-Induced Lymphoma After Heart Transplantation: A Case Report	33
Recurrence of pulmonary arterial hypertension 32 months after bilateral lung transplant	33
Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?	32
MTHFD2 ablation in T cells protects against heart transplant rejection by perturbing IRF4/PD-1 pathway through the metabolic-epigenetic nexus	31
Molecular criteria for pulmonary antibody-mediated rejection are associated with an increased risk of allograft failure	31
The impact of cardiovascular and lung comorbidities in patients with pulmonary arterial hypertension: A systematic review and meta-analysis	31
First North American Experience with The Berlin Heart Active Driver	31
Pediatric Heart Transplantation in Donation After Circulatory Death Using Normothermic Regional Perfusion - Early Experience with Small Donors	31
Global Outcomes with Extended Criteria Donors When Preserved at 4-8°C: An Updated Analysis of the International GUARDIAN Heart Registry	30
Hemodynamic Effects of Impella 5.5 in Cardiogenic Shock and Acute Decompensated Heart Failure	30
Extending the bridge, bridging the gap	30
Mollicute Infections in Lung Transplant Patients: A Retrospective Review of Recipient Infections Post Initiation of a Screening Protocol	29
Conversion from Immediate Release Tacrolimus to LCP-Tacrolimus in Heart Transplant Recipients	29
Outcomes in Children Supported with Paracorporeal Continuous Compared to Paracorporeal Pulsatile Ventricular Assist Devices	29
Immunologic Outcomes Following Mycophenolate Dose Reduction in Lung Transplant Recipients	28
Letermovir Use for Cytomegalovirus Prophylaxis in Lung Transplant Recipients	28
Outcomes After Heart Transplantation from Donors After Circulatory Death versus Brain Death: A Systematic Review and Meta-Analysis	28
The Use of Ambulatory Blood Pressure Monitoring in Pediatric Heart Transplant Recipients	27
SRC Homology and Collagen (Shc) Inhibition: A Novel Therapeutic Strategy for Transplant-Related Pulmonary Fibrosis	27
Early Outcomes from the Use of Thoracic Epidural Analgesia versus INC Cryoablation during Lung Transplantation - A Single Center Experience	27
Pharmacist Managed Timing of Peri-Operative Plasmapheresis and Anti-Thymocyte Globulin in Heart Transplantation	26
Sternal Closure After Clamshell Thoracotomy for Bilateral Lung Transplantation: Comparison Between Different Techniques	26
Acute Myocarditis: Trying to Dissect Potential Prognostic Factors	26
Post Transplant Malignancy Risk Factors in Thoracic Solid Organ Transplant Recipients	25
Influence of Risk Factors on PTLD-Free Probability in Lung Transplant Patients: SRTR Database Analysis	25
An Uncommon Driver of Waitlist Urgency: Recurrent Secondary Spontaneous Pneumothoraces of the Lung Allograft in a Single Lung Transplant (SLT) Recipient with CLAD	25
Use of Heart in Donor Death Caused by Lightning	25
A Single Centre Review of INR Monitoring in Patients Implanted with HeartMate 3 Ventricular Assist Device	25
Impact of Donor Transfusions on Lung Transplant Outcomes: A National Cohort Analysis	25
Activation of cGAS-Dependent Necroptosis during Cold Static Preservation of Lungs Relies on Calcium	25

Single Nuclei Transcriptomic Analysis of Heart Allograft Ischemia-Reperfusion in a Rat Model	25
Donor Factors Contributing to the Increase in Adult Heart Transplant Volume in the United States	24
End Stage Heart Failure in Systemic Sclerosis- From Mechanical Circulatory Support to Heart Transplant	24
Midterm Outcomes in Orthotopic Heart Transplant Recipients with a History of Methamphetamine Use	24
Effect of Heparin Coated ECMO Circuit on AntiPF4 Antibodies	24
A Bold Look: Evaluation of Skeletal Muscle Microvascular Function in Pediatric Heart Transplant Recipients Using Post-Contractile Blood Oxygen Level Dependent MRI	24
Table of Contents	23
Hypogammaglobinemia in Patients Palliated with the Fontan Circulation: Implications for Cardiac Transplantation	23
(120) Heart Preservation with the Organ Care System in Extended Criteria Donor Hearts: A Single Center Experience	23
Information for Readers	23
Alveolar macrophage subsets: Accessories to lung alloimmune rejection	23
(908) Does Donor-Recipient Sex Mismatch Have an Influence on Long Term Outcomes after Lung Transplantation? An Experience of a High Volume Center	23
(904) Early Weight Gain During Ex Vivo Lung Perfusion Can Predict Transplant Suitability and Post-Transplant Outcomes	23
Evaluating age-based eligibility thresholds for heart re-transplantation – an analysis of the united network for organ sharing database	23
Hemodynamic Modeling for Mitral Regurgitation	23
(911) Older Donors in Lung Transplantation: The Portuguese Experience	23
(1215) Think Inside The Box: Constrictive Pericarditis after Pediatric Lung Transplant	23
Information for Readers	23
(1188) Assessment of Dd-cfDNA Between Stable Single and Double Lung Recipients	22
(849) The Utility of Mechanical Circulatory Support in the Management of Massive Pulmonary Embolism with Right Ventricular Failure	22
(782) Use of Extracorporeal Membrane Oxygenation in Ranolazine Overdose	22
(742) Prognostic Value of Donor Specific Human Leukocyte Antibodies in Pre-Sensitized Heart Transplant Patients	22
(1206) Clinical Implications of Microbiome on Acute Rejection in Lung Transplant Recipients	22
(811) Incidence of Right Ventricular Dysfunction in Lvad Patients Bridged with High Dose Inotropes	22
(151) Plasma Proteomic Signature of Human Heart Transplant Recipients After Restoration of Blood Circulation and Its Relationship to Graft Outcome	21
(1226) Serum Proteomics for Fibrotic Markers in Early Detection of Bronchiolitis Obliterans Syndrome after Lung Transplantation	21
Cardiac output assessment methods in left ventricular assist device patients: A problem of heteroscedasticity	21
(888) Initiating an ECMO Program at a Safety Net Hospital During a Global Pandemic	21
ISHLT 2023 Author Index	21
(384) Urine Exosomes for Kidney Health Assessment in Mechanical Circulatory Support	21
Immune Characterization of a Xenogeneic Cross Circulation System for Ex Vivo Human Lung Support	21
(797) Implantation from Short Term MCS to Durable VAD: Single Center Experience	21
Predictors of One-Year Outcome in Patients Undergoing Cardiac Re-Transplantation: Machine Learning Analysis	21
What's in a name: The importance of lung transplant at Cystic Fibrosis Foundation Accredited Care Centers for patients with Cystic Fibrosis	21
Imaging Mass Cytometry for Detailed Cellular and Spatial Characterization of Chronic Lung Allograft Dysfunction (CLAD)	20
Early Mammalian Target of Rapamycin Inhibitor Utilization After Heart Transplantation: Analysis of the UNOS Database	20
The Normalised Acute Rejection Score in the First Year Post Transplant and Its Association with CLAD	20
Polymicrobial and Multiple Blood Stream Infection Episodes as Risk Factors for On-Pump Mortality in Mechanical Circulatory Support Patients	19
Ventricular Arrhythmias and Implantable Cardioverter-Defibrillator Use in Patients with Left-Ventricular Assist Device: Validation of the VT-LVAD Prediction Score	19
Safety of Single Lung Transplantation Post Donation Service Area-Specific Organ Distribution	19
Kidney Transplantation in Single Ventricle Palliated Patients: A Pediatric Cardiac Care Consortium Study	19
Comparison of LVAD Admissions Before and During the Era of COVID-19	19
(472) Giant Cell Myocarditis with LVAD Presenting with Acute Severe AI Managed with Valve-In-Valve TAVI	19
(715) Diaphragm Dysfunction from Covid-19 Phrenic Neuropathy: Utilization of Diaphragm Pacing for Recovery	19
Predictors of Failure to Rescue After Left Ventricular Assist Device Implantation	19
Challenges in Heart Transplantation During COVID-19 Pandemic in Brazil	19
Heart Transplantation Utilizing Organs Following Donation After Circulatory Death (DCD)	19
Decoupling Between Pulmonary Artery Diastolic and Wedge Pressure Following TAVR	19
(1153) Characterization of CD3-Guided Anti-Thymocyte Globulin Dose Minimization for Renal Sparing Induction after Heart Transplant	18
Extending the Transplant Practitioner Role within the National Organ Retrieval Team to Include Organ Care Practitioner	18
Sequential Double-Lung Transplantation in Kartagener Syndrome: A Case Report	18
Pulmonary Hypertension and Diastolic Heart Failure in an Adolescent African-American Cantú Syndrome Patient	18
(1270) Thermal Preconditioning During EVLP Reduces T Lymphocytes and Increases Monocytes and Neutrophils Contents in the Perfusion Solution	18
Using Donor Lungs ≥70 Years of Age for Transplantation - Do Long-Term Outcomes Justify the Use?	18
Oral Aversion and Its Risks in Pediatric Heart Transplant Recipients	18
Bedside Ultrasound of Internal Jugular Vein for Right Ventricular Function Assessment	18
(324) Stanford Pediatric Psychosocial Optimization Tool for Transplant	18
(1033) Effect of Practice Variation Amongst Organ Procurement Organizations on Pediatric Donor Heart Utilization	18
Use of a Medication Questionnaire to Identify Lung Transplant Recipients Benefiting from Pharmacist Prioritization in Clinic	18
(854) Effect of Dobutamine on Rv Contractility and Rv-Pa Coupling in the Normal Rv	18
Optimizing the handling of missing data in the UNOS database	17
Extra-cardiac management of cardiogenic shock in the intensive care unit	17
Hemodynamic Implications of Sildenafil in Candidates for Heart Transplantation with Group 2 Pulmonary Hypertension: A Single Latin-American Center Registry	17
Cold Blood Cardioplegia Use for Cardiac Arrest After Heart Transportation with Organ Care System May Improve Outcomes	17
Social Determinants of Health, Race and Their Relationship to Time in Therapeutic INR Range Following LVAD Implantation	17
Duration of Donor Cardiac Downtime in Donors After Circulatory Death Transplant	17
When a Single Choice Impacts a Single Ventricle: Paracorporeal Pediatric VAD Support at 544 Days	17
Sotrovimab in pediatric cardiac transplant recipients with SARS-CoV2 infection	17
Center volume effect on acute cellular rejection and outcomes in pediatric lung transplant recipients	17
Lung Transplantation for Primary Ciliary Dyskinesia - A Single Center Review	17
Impact of Logistic Challenges on Cardiac Transplantation	17
New Rules, Improved Results: Successful Outcomes Bridging Patients Listed Status 1 for Heart Transplantation	17
Argon Inhalation Reduces Pulmonary Ischemia-Reperfusion Injury in MHC-inbred CLAWN Miniature Swine	17
Impact of coronary hypoperfusion during agonal phase on outcomes following donation after circulatory death heart transplantation	17
Backwash Maneuver in LVAD Inflow Thrombosis: A Single-Center Experience (2015-2024)	17
Comparing the Outcomes of Combined Heart-Liver Transplant Recipients from DCD and Non-DCD Donors: An Analysis Using the UNOS Database	17
Survival After Combined Lung and Liver Transplantation: A 22-year Single-Centre Retrospective Study	17
Improved Oxygenation and Atelectasis in Brain-Dead (BD) Donors with a Novel Percutaneous Transvenous Phrenic Nerve Stimulator	17
Enhancing Post-Lung Transplant Care with AlloHome: Early Impact Evaluation	16
DCD heart transplantation with NRP: Excellent results and a continued uphill battle	16

Hepatitis B Virus Reactivation in Lung Transplant Recipients with Previous Resolved Infection	16
Donor heart ischemic time can be extended beyond 9 hours using hypothermic machine perfusion in sheep	16
Early Detection of Baseline Lung Allograft Dysfunction: The Concept of Pre-BLAD	16
Letter to the Editor: Can the grading of mild cardiac allograft vasculopathy be further refined? An angiographic and physiologic assessment of heart transplant recipients with ISHLT CAV 1	16
Pseudomonas-dominant microbiome elicits sustained IL-1β upregulation in alveolar macrophages from lung transplant recipients	16
Lung Transplantation from hepatitis C+ donor lungs: Reassuring midterm outcomes	16
Lactic Acid and Metabolic Analysis of Human Donor Hearts Preserved with Organ Care System	16
Risk stratification in patients with pulmonary arterial hypertension at the time of listing for lung transplantation	16
Extended Hypothermic Cardiac Preservation Using the VP.S ENCORE® Device Leads to Enhanced Cardiac Function in a Pilot Orthotopic Porcine Heart Transplant Study	16
Re-evaluating ischemic tolerance and prognostic accuracy in DCD cardiac transplantation: A critical appraisal of taNRP outcomes	15
The human cytomegalovirus-specific and UL40-mediated imprint in the natural killer cell repertoire is associated with antibody-mediated rejection in lung transplant recipients	15
A rare case of late onset tacrolimus-induced leukoencephalopathy and coma after pediatric orthotopic heart transplantation	15
“Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World”	15
Metabolomic Signature of RV–PA Coupling Differentiates Haemodynamic Response to Imatinib Therapy in Pulmonary Arterial Hypertension	15
Functional status predicts pediatric heart transplant outcomes: A united network for organ sharing (UNOS) database study	15
Current Global Trends and Challenges Utilizing Pediatric Ventricular Assist Devices: An Action Collaborative Survey	15
Table of Contents	15
Kidney function assessment using cystatin C and serum creatinine in heart transplantation recipients: Implications for valganciclovir dosing	15
Determining the impact of ex-vivo lung perfusion on hospital costs for lung transplantation: A retrospective cohort study	15
Lung transplantation following donation after thoraco-abdominal normothermic regional perfusion (TA-NRP): A feasibility case study	15
Normothermic Ex Vivo Lung Perfusion (Novel) as an Assessment of Extended Criteria Donor Lungs: A Prospective Multi-Center Clinical Trial	15
The evaluation of constant coronary artery flow versus constant coronary perfusion pressure during normothermic ex situ heart perfusion	15
Microcirculation as a Predictor of Clinical Outcomes in Left Ventricular Assist Device Therapy	15
Combination Approach of Perioperative Plasmapheresis and Eculizumab for Highly Sensitized Lung Transplant Patients	15
Towards a nuanced understanding of donor risk	15
Daratumumab monotherapy as a desensitization strategy prior to cardiac transplantation	15
Pulmonary artery fresh floating thrombus in patients with chronic thromboembolic pulmonary hypertension on low-dose direct oral anticoagulants: A single-center angiographic observational study	15
Contemporary outcomes of mechanical circulatory support using paracorporeal continuous flow pump in children: A report from the ACTION learning network	15
Durable Ventricular Assist Device Support with Systemic Right Ventricle Cannulation	15
Blockade of BLyS inhibits B-cell responses and antibody production for the prevention of chronic transplant rejection	15
Does Donor-Recipient Age Mismatch Affect Long-Term Immunological Outcomes? A 10-Year Single Center Study	15
Shock Teams Grow Volume and Improve Outcomes in Cardiogenic Shock	15
WITHDRAWN	15
Patients with Acute Lung Rejection Have a Worse Outcome After Combined Heart-Lung Transplantation	14
Evaluating Postoperative Outcomes of Heart Transplant Recipients from Active COVID19 Positive and Negative Donors Using Induction Therapy	14
Reversion of Val(ganciclovir)-Resistance Associated Mutation in Two SOT Patients with Mismatch Serostatus for CMV (D+/R-)	14
Gut Reaction: Gastroesophageal Reflux Fuels De Novo DSA Development After Lung Transplant	14
Application of Optical Mapping for Assessing Ischemic Regions in Donor Hearts: A Novel Approach to Monitoring Action Potential Hysteresis and Triangulation	14
Left Ventricular Stenting - A Novel Technique for LVAD Implantation in Patients with Restrictive Cardiomyopathy	14
Hemodynamics at Submaximal Exercise Independently Predict Outcomes in Severe Heart Failure	14
Kratom Toxicity: A Mimicker of Fulminant Myocarditis	14
Early Rejection and Graft Vasculopathy in DCD Hearts: A Comparison of Recovery Methods	14
Differences in Prevention, Diagnosis, Surveillance and Treatment of Cardiac Allograft Vasculopathy in Heart Transplant Patients: Results of an International Survey	14
Improving Efficiency in Pharmacist Led Thoracic Transplant Patient Medication Education	14
Plasmablastic Lymphoma in a Lung Transplant Recipient	14
A Rare Case of HeartMate 3 Pump Stoppage	14
Impact of Preoperative Opioid Use in Lung Transplant Recipients	14
Initial Analysis of Immune Phenotypes in Heart Transplant Recipients of the ALL IN HEART (Tocilizumab) Trial	14
Long-Term Outcomes of Ventricular Assist Devices in Obese Pediatric Patients: An ACTION Registry Study	14
MHC Class II Matching Does Not Predict Survival in Organ and Bone Marrow Transplantation in Non-Human Primates	14
Tuberculosis Post Lung Transplantation - An Indian Experience	14
Porcine Mitochondria Transplantation in Human iPS-Cardiomyocytes and Intact Hearts	14
Esophagogastric Junction (EGJ) Outflow Obstruction is Associated with Chronic Lung Allograft Dysfunction (CLAD)	13
Use and Outcomes of Ex-Vivo Machine Perfusion (EVMP) in Donation After Brain Death (DBD) Heart Transplantation (HT)	13
Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis	13
Selection of lung transplant candidates: A pediatric perspective on the International Society for Heart and Lung Transplantation consensus document	13
Outcome-based Risk Assessment of Non-HLA Antibodies in Heart Transplantation: A Systematic Review	13
ADAM10-Mediated VE-Cadherin Shedding May Increase the Risk of Sepsis for Heart Failure Patients Supported by Continuous-Flow Left Ventricular Assist Devices	13
First Sub-Zero Cardiac Allograft Preservation and Reanimation Following 24-Hours of Isochoric Supercooled Preservation	13
Does Gastrointestinal Bleeding Increase the Risk of Thromboembolic Events in Patients Supported with CF-LVADs?	13
Extended survival of 9- and 10-gene-edited pig heart xenografts with ischemia minimization and CD154 costimulation blockade-based immunosuppression	13
Outcomes of Explanted LVAD Patients with Heart Failure Relapse Requiring Heart Replacement Therapies: A VAD Wean Registry Analysis	13
Use of Newer Intravascular Microaxial Ambulatory Left Ventricular Assist Devices as a Bridging Strategy for Cardiogenic Shock in Adult Congenital Heart Disease Patients	13
Donor Heart Preservation at 4-8°C Using Moderate Hypothermic Donor Heart Preservation Improves 4-year Survival in the US Guardian-Heart Registry	13
The Impact of Functional Warm Ischemia Time on Procurement and Preservation Technique in DCD Heart Transplantation	13
(66) Lower Neighborhood Opportunity is Associated with Worse Outcomes after Listing in Pediatric Heart Transplantation	13
Largest Real-World Multi-Center Study Outcomes Reported with Controlled Hypothermic Preservation of Donor Lungs	13
Upfront riociguat and ambrisentan combination therapy for newly diagnosed pulmonary arterial hypertension: A prospective open-label trial	12
CD38 Antibody Daratumumab as an Add-On Rescue Therapy for AMR - First Report in Clinical Lung Transplantation	12
Cardiac function recovery after 20-min hands-off using thoracoabdominal-normothermic regional perfusion	12
Outcomes of donation after circulatory death (DCD) and ex-vivo lung perfusion (EVLP) lung transplantation	12
Donor sequence number is not associated with worse lung transplant outcomes regardless of transplant center case volume	12
SAFETY OF BALLOON PULMONARY ANGIOPLASTY IN CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION	12
Axillary Temporary Mechanical Circulatory Support to Bridge Cardiogenic Shock Patients to Heart Transplantation	12
Donor-Derived Cell-Free DNA as a Biomarker for the Effect of Daratumumab in Patients with Antibody-Mediated Rejection Post-Heart Transplant	12
Mechanical Stretch Reduces Fibroblast Activation in Heart Failure with Reduced Ejection Fraction	12
Absolute quantification of donor-derived cell-free DNA following pediatric and adult heart transplantation	12
Study of angiogenic cell therapy for progressive pulmonary arterial hypertension: intervention with repeat dosing of eNOS-enhanced EPCs: the SAPPHIRE trial	12
Digoxin Reverses Angiogenic Dysregulation During HeartMate 3 Support by Inhibiting the HIF1-a Signaling Cascade and is Associated with Decreased Risk for Gastrointestinal Bleeding	12
Influence of Environmental Temperature on the Occurrence of Driveline Infection in LVAD Patients	12
Dapagliflozin Use in Children with Heart Failure Undergoing Heart Transplantation	12
Non-Ischemic Preservation of the Donor Heart in Heart Transplantation - A Randomized, Controlled, Multicenter Trial Using The Xvivo Heart Assist Preservation System for Hypothermic Oxygenated Perfusio	12
Barriers and opportunities in donation after circulatory death heart transplantation	12
Lung Ultrasound for Diagnosis of Primary Graft Dysfunction in Lung Transplantation Recipients	12
Unlocking the black box of heart preservation	12
Identification and Clinical Course of Novel Pathogenic Variant of Transthyretin Amyloid Cardiomyopathy: P.arg54lys	12
Between Metrics and Measures: KCCQ, CPET, and HF Prognosis	11
Enhancing Exercise Capacity in Exercise-Induced Pulmonary Hypertension: A Retrospective Study of Riociguat Therapy	11
The cGAS-Sting Pathway Drives Alveolar Epithelial Cell Death via Non-Canonical PKR Signaling During Lung Ischemia-Reperfusion Injury	11
Donor Chimerism Duration Correlates with Heart Allograft Tolerance in Combined Heart and Bone Marrow Transplantation in Nonhuman Primates	11
Heart Transplant Outcomes in Higher Risk Recipients	11
Delayed Presentation of Hyperammonemia Syndrome After Lung Transplant	11
Lung Transplantation in Patients with Hermansky-Pudlak Syndrome	11
Absent Sounds: Use of Haptic Devices for LVAD Alarms in a Patient with Hearing Loss	11
A Case Series of Gastrointestinal Bleeding Related to Arteriovenous Malformations with Impella 5.5	11